Login / Signup

Unraveling NEK4 as a Potential Drug Target in Schizophrenia and Bipolar I Disorder: A Proteomic and Genomic Approach.

Chengcheng ZhangZhiHui YangXiaojing LiLiansheng ZhaoWanjun GuoWei DengQiang WangXun HuMing LiPak Chung ShamXiao XiaoTao Li
Published in: Schizophrenia bulletin (2024)
These findings underscore a shared genetic origin for SCZ and BD-I, offering novel insights for potential therapeutic target identification.
Keyphrases
  • bipolar disorder
  • copy number
  • human health
  • genome wide
  • emergency department
  • gene expression
  • risk assessment
  • adverse drug